ATE315402T1 - USE OF ONE OR MORE NATURAL OR MODIFIED OXYGEN BINDERS FREE OF PLASMA AND CELL WALL COMPONENTS FOR THE EXTERNAL TREATMENT OF OPEN, PARTICULARLY CHRONIC WOUNDS - Google Patents

USE OF ONE OR MORE NATURAL OR MODIFIED OXYGEN BINDERS FREE OF PLASMA AND CELL WALL COMPONENTS FOR THE EXTERNAL TREATMENT OF OPEN, PARTICULARLY CHRONIC WOUNDS

Info

Publication number
ATE315402T1
ATE315402T1 AT03708173T AT03708173T ATE315402T1 AT E315402 T1 ATE315402 T1 AT E315402T1 AT 03708173 T AT03708173 T AT 03708173T AT 03708173 T AT03708173 T AT 03708173T AT E315402 T1 ATE315402 T1 AT E315402T1
Authority
AT
Austria
Prior art keywords
chronic wounds
plasma
natural
open
external treatment
Prior art date
Application number
AT03708173T
Other languages
German (de)
Inventor
Wolfgang Barnikol
Alexander Teslenko
Original Assignee
Sanguibiotech Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanguibiotech Gmbh filed Critical Sanguibiotech Gmbh
Application granted granted Critical
Publication of ATE315402T1 publication Critical patent/ATE315402T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to the use of one or more natural or modified oxygen carriers, devoid of plasma or cellular membrane constituents, for the production of an agent for the external treatment of open wounds, particularly chronic wounds. Hemoglobin or myoglobin of human or animal origin are suitable as oxygen carriers. The oxygen carriers can also preferably be modified. Suitable modifications are cross-linking, reaction with polyalkylene oxides, chemically reactive or chemically non-reactive effectors, or combinations. The agent is applied to the wound area particularly by means of spraying on an aqueous solution containing the oxygen carrier(s). The oxygen carriers can be used in particularly effective manner in the case of chronic wounds resulting from tissue degeneration, particularly diabetic tissue degeneration.
AT03708173T 2002-03-20 2003-03-04 USE OF ONE OR MORE NATURAL OR MODIFIED OXYGEN BINDERS FREE OF PLASMA AND CELL WALL COMPONENTS FOR THE EXTERNAL TREATMENT OF OPEN, PARTICULARLY CHRONIC WOUNDS ATE315402T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10212321A DE10212321A1 (en) 2002-03-20 2002-03-20 Use of one or more natural or modified oxygen binders freed from plasma and cell wall components for the external treatment of open, in particular chronic wounds

Publications (1)

Publication Number Publication Date
ATE315402T1 true ATE315402T1 (en) 2006-02-15

Family

ID=27815794

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03708173T ATE315402T1 (en) 2002-03-20 2003-03-04 USE OF ONE OR MORE NATURAL OR MODIFIED OXYGEN BINDERS FREE OF PLASMA AND CELL WALL COMPONENTS FOR THE EXTERNAL TREATMENT OF OPEN, PARTICULARLY CHRONIC WOUNDS

Country Status (7)

Country Link
US (1) US20050129747A1 (en)
EP (1) EP1485120B1 (en)
AT (1) ATE315402T1 (en)
AU (1) AU2003212300A1 (en)
DE (2) DE10212321A1 (en)
ES (1) ES2255669T3 (en)
WO (1) WO2003077941A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2610579T3 (en) 2003-12-18 2017-04-28 Metronom Health, Inc. Stabilized oxygen transport matrix
WO2008034138A1 (en) * 2006-09-15 2008-03-20 The Ohio State University Research Foundation Methods and compositions for the topical oxygenation of hypoxic tissue
FR2907683A1 (en) * 2006-10-27 2008-05-02 De Potter Philippe Viseux Medical composition, useful to prepare drug to regenerate wounded tissues and as bandage for healing wounds, comprises combination of two molecules comprising glucose and insulin
EP2201951A1 (en) 2008-11-14 2010-06-30 Ahmet Melih Aydinoglu Octenidine composition
ME02979B (en) 2009-06-09 2018-10-20 Prolong Pharmaceuticals Llc Hemoglobin compositions
US10172949B2 (en) 2009-06-09 2019-01-08 Prolong Pharmaceuticals, LLC Hemoglobin compositions
US10172950B2 (en) 2009-06-09 2019-01-08 Prolong Pharmaceuticals, LLC Hemoglobin compositions
WO2012094679A2 (en) * 2011-01-07 2012-07-12 Vindico NanoBio Technology Inc. Compositions and methods for delivery of high-affinity oxygen binding agents to tumors
ES2432075T3 (en) 2011-07-23 2013-11-29 Sastomed Gmbh Wound spray
EP2614833A1 (en) * 2012-01-13 2013-07-17 SastoMed GmbH Scarring reducing wound treatment
US10729748B2 (en) * 2012-01-13 2020-08-04 Mölnlycke Health Care Ab Scarring reducing wound treatment
US10456452B2 (en) 2015-07-02 2019-10-29 Poseida Therapeutics, Inc. Compositions and methods for improved encapsulation of functional proteins in polymeric vesicles
US11553879B2 (en) 2015-09-02 2023-01-17 Metronom Health, Inc. Systems and methods for continuous health monitoring using an opto-enzymatic analyte sensor
WO2017190091A1 (en) 2016-04-29 2017-11-02 Vindico Nanobiotechnology, Llc Poly(histidine)-based micelles for complexation and delivery of proteins and nucleic acids
JP7387597B2 (en) 2017-07-18 2023-11-28 ヴァーテック・バイオ・インコーポレイテッド Blood substitute containing hemoglobin and production method

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2527210A (en) * 1944-01-25 1950-10-24 John O Bower Hemoglobin solution and method
DE3412144A1 (en) * 1984-03-31 1985-10-10 Biotest Pharma GmbH, 6000 Frankfurt METHOD FOR PRODUCING HIGHLY CLEANED, ELECTRICITY-FREE, HEPATITIC-SAFE HUMAN AND ANIMAL HEMOGLOBIN SOLUTIONS
JPH11513709A (en) * 1995-10-26 1999-11-24 バクスター・インターナショナル・インコーポレイテッド Therapeutic use of hemoglobin in promoting wound healing
US6160021A (en) * 1997-02-04 2000-12-12 The General Hospital Corporation Method for treating epidermal or dermal conditions
DE10031741A1 (en) * 2000-06-29 2002-01-17 Sanguibio Tech Ag Externally applied oxygen carrier preparation for treating oxygen deficiency states of the skin, comprises active agent, specifically hemoglobin or its mixture with myoglobin, incorporated in a gel carrier
DE10034970B4 (en) * 2000-07-19 2004-11-18 Sanguibiotech Gmbh An oxygen carrier, selected from hemoglobin or a preparation containing hemoglobin and myoglobin in the form of an emulsion, and its use as a cosmetic external and for the natural regeneration of the skin in the absence of oxygen

Also Published As

Publication number Publication date
ES2255669T3 (en) 2006-07-01
US20050129747A1 (en) 2005-06-16
DE50302187D1 (en) 2006-04-06
AU2003212300A1 (en) 2003-09-29
WO2003077941A1 (en) 2003-09-25
EP1485120B1 (en) 2006-01-11
EP1485120A1 (en) 2004-12-15
DE10212321A1 (en) 2003-10-09

Similar Documents

Publication Publication Date Title
DE50302187D1 (en) USE OF ONE OR MORE OF PLASMA AND CELL WALL COMPONENTS FREE NATURAL OR MODIFIED OXYGEN BINDERS FOR EXTERNAL TREATMENT OF OPEN, PARTICULARLY CHRONIC WOUNDS
HK1122803A1 (en)
DE602004013792D1 (en) USE OF C-KIT INHIBITORS FOR THE TREATMENT OF TYPE-2 DIABETES
ATE259644T1 (en) TREATMENT OF ERYTHROCYTES CONTAINING HEMOGLOBIN WITH NITROGEN OXIDE
EA200901555A1 (en) LOCAL APPLICATION COMPOSITION FOR SKIN CARE AND TREATMENT METHOD
FR2822701B1 (en) USE OF ALGAE PHAEODACTYLUM EXTRACT AS A COSMETIC AGENT PROMOTING PROTEASOME ACTIVITY OF SKIN CELLS AND COSMETIC COMPOSITION CONTAINING SAME
CA2382569A1 (en) Super-oxidized water, preparation and use therefor as sterilizers and medicaments
WO2006062679A3 (en) Bandage and method for vital bleaching of skin
ATE405650T1 (en) PRODUCTION OF WHOLE ANTIBODIES IN PROKARYONTIC CELLS
ATE464921T1 (en) APPLICATOR FOR A WATERJET SEPARATOR, PARTICULARLY FOR THE TREATMENT OF WOUNDS AND ULCERS
ATE322162T1 (en) PHOTOSENSITISER CONTAINING STORAGE SOLUTION FOR INACTIVATION OF BIOLOGICAL CONTAMINANTS
EA200400482A1 (en) KERATINOCYCES SUITABLE FOR APPLICATION AS A BIOLOGICALLY ACTIVE SUBSTANCE IN THE TREATMENT OF THE RAS
ATE449617T1 (en) HYDROGEL FOR WOUND TREATMENT
WO2006094070A3 (en) Human skin equivalents expressing exogenous polypeptides
EA200970294A1 (en) METHOD FOR THE EXTENSION OF STEM CELLS OF ADULT ORGANISM FROM THE BLOOD, IN PARTICULAR PERIPHERAL, AND CORRESPONDENT USE IN THE FIELD OF MEDICINE
GEP20115215B (en) Method for treating ovulated eggs of aquatic animals and ovulated eggs prepared by said method
ATE553760T1 (en) USE OF ALVERINE TO TREAT SKIN DISEASES
RU2011148938A (en) TREATMENT OF SURFACE BODY INFECTION OR ANIMAL
RU2009116833A (en) G-CSF-CONTAINING AGENT FOR PREVENTING AND TREATING DIABETIC PERIPHERAL NEUROPATHY
ATE420845T1 (en) PROCESSING OF REACTION SOLUTIONS FROM WHOLE CELL BIOTRANSFORMATIONS
CN106729940A (en) A kind of spacetabs type long acting antibiotic carries silver-colored dressing and preparation method thereof
RU2006126490A (en) METHOD FOR TREATING INFECTED RAS
WO2007062868A3 (en) Porous and biocompatible carrier material for treating bone and/or cartilage defects
RU2005100533A (en) Means for accelerating wound healing
CY1111319T1 (en) 4-Methyl-hexanoic acid compound F

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee